Mestag awarded 拢1.5m grant to revolutionise cancer treatment
Cambridge-based BioTech company Mestag Therapeutics has been awarded a 拢1.5 million Transforming Cancer Therapeutics grant. The money comes from Innovate UK鈥檚 Cancer Therapeutics program to accelerate the development of its MST-0300 antibody. Innovate UK, part of UK Research and Innovation, is investing a total of 拢12m in innovation projects to advance next-generation immunotherapies for cancer. … Continue reading Mestag awarded 拢1.5m grant to revolutionise cancer treatment
